Obesity Surgery

, Volume 27, Issue 10, pp 2546–2551 | Cite as

Efficacy of Intragastric Balloon Treatment for Adolescent Obesity

  • Ricardo José Fittipaldi-Fernandez
  • Marcella Rodrigues Guedes
  • Manoel P. Galvao Neto
  • Márcia Regina Simas Torres Klein
  • Cristina Fajardo Diestel
Original Contributions
  • 246 Downloads

Abstract

Background

Several studies conducted in adults suggest that intragastric balloon (IGB) is an effective and safe method for weight loss. Although the prevalence of obesity in adolescents has increased in recent years, the outcomes of IGB treatment in this age group are not known. The aim of this study was to evaluate the safety and efficacy of IGB treatment for weight loss in adolescents followed up for 6 months.

Methods

This is a retrospective longitudinal study including 27 adolescents (14–19 years; 23 female). All participants were referred to IGB treatment by their attending physician, presented body mass index (BMI) ≥ 29 kg/m2 (>p97 BMI/age index) and failed to lose weight in clinical treatments. A liquid-filled nonadjustable IGB with a volume of 600 to 700 ml was used for 6 months. All patients were included in a multidisciplinary program, and adherence to this program was evaluated as the number of attended appointments.

Results

There were no serious complications or deaths. The BMI decreased from 37.04 to 31.18 kg/m2 (p < 0.0001), body weight decreased from 102.21 to 86.23 kg (p < 0.0001), and excess weight diminished from 35.18 to 19.12 kg (p < 0.0001). The % excess weight loss (%EWL) was 56.19 and % total weight loss (%TWL) 16.35. Adherence to the multidisciplinary program correlated directly with %EWL (r = 0.55; p = 0.0033) and %TWL (r = 0.53; p = 0.0052).

Conclusion

Endoscopic treatment of obesity with an IGB is safe, effective, and may be an emerging therapeutic option for adolescents.

Keywords

Intragastric balloon Obesity Overweight Adolescents Weight loss 

References

  1. 1.
    Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–14.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    National Center for Health Statistics. Health, United States. With special features on socioeconomic status and health. Hyattsville: U.S. Department of Health and Human Services; 2012; 2011. Available from: https://www.cdc.gov/nchs/data/hus/hus11.pdf Google Scholar
  3. 3.
    Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    World Health Organization. Factsheet: obesity and overweight. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  5. 5.
    Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111(15):1999–2012.CrossRefPubMedGoogle Scholar
  6. 6.
    Kelly AS, Barlow SE, Rao G, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation. 2013;128(15):1689–712.CrossRefPubMedGoogle Scholar
  7. 7.
    Freedman DS, Zuguo M, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart study. J Pedriatr. 2007;150(1):12–7.CrossRefGoogle Scholar
  8. 8.
    Singh AS, Mulder C, Twisk JW, et al. Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev. 2008;9(5):474–88.CrossRefPubMedGoogle Scholar
  9. 9.
    Jensen MD, Ryan DH, Apovian CM, et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2013;63(25PtB):2985–3023.PubMedGoogle Scholar
  10. 10.
    Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015;8(6):402–24.CrossRefPubMedGoogle Scholar
  11. 11.
    Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004;12:1197–211.CrossRefPubMedGoogle Scholar
  12. 12.
    Yeste D, Carracosa A. Management of obesity in childhood and adolescence: from diet to surgery. Endocrinol Nutr. 2012;59(7):403–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of intragastric balloon. Obes Surg. 2004;14:991–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Roman S, Napoléon B, Mion F, et al. Intragastric balloon for “non-morbid” obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.CrossRefPubMedGoogle Scholar
  15. 15.
    Leeman MF, Ward C, Duxbury M, et al. The intra-gastric balloon for pre-operative weight loss in bariatric surgery: is it worthwhile? Obes Surg. 2013;23(8):1262–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Vandenplas Y, Bollen P, De Langhe K, et al. Intragastric balloons in adolescents with morbid obesity. Eur J Gatroenterol Hepatol. 1999;11(3):243–5.CrossRefGoogle Scholar
  17. 17.
    Karagiozoglou-Lampoudi T, Papakostas P, Penna S, et al. Effective intragastric balloon treatment in obese adolescents. Ann Gastrenterol. 2009;22(1):46–51.Google Scholar
  18. 18.
    Reece LJ, Sachdev P, Copeland RJ, et al. Intra-gastric balloon as an adjunct to lifestyle support in severely obese adolescents; impact on weight, physical activity, cardiorespiratory fitness and psychosocial well-being. Int J Obes (Lond). 2016; doi:10.1038/ijo.2016.192. Google Scholar
  19. 19.
    WHO. Growth reference data for 5-19 years, 2007 (http:// http://www.who.int/growthref/en/)
  20. 20.
    Ali MR, Moustarah F, Kim JJ. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. SurgObesRelatDis. 2016;12(3):462–7.Google Scholar
  21. 21.
    Mion F, Napoléon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in nonmorbid obese patients. Obes Surg. 2005;15:510–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Lee DY, Guend H, Park K, et al. Outcomes of laparoscopic roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding in adolescents. Obes Surg. 2012;22(12):1859–64.CrossRefPubMedGoogle Scholar
  23. 23.
    Silva GM, Osório A, Pereira F, et al. Effect of laparoscopic adjustable gastric banding on modifiable cardiovascular risk factors in extremely obese adolescents. Obes Surg. 2012;22(6):991–4.CrossRefPubMedGoogle Scholar
  24. 24.
    Yorke E, Switzer NJ, Reso A, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26(9):2249–54.CrossRefGoogle Scholar
  25. 25.
    Genco A, Bruni T, Doldi SB, et al. Bio Enterics Intragastric balloon: the Italian experience with 2, 515 patients. Obes Surg. 2005;15(8):116–4.CrossRefGoogle Scholar
  26. 26.
    Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity: a meta-analysis. Obes Surg. 2008;18(7):841–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Lopez-Nava G, Rubio MA, Prados S, et al. Bio Enterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21(1):5–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Stimac D, Majanovic SK, Turk T, et al. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg. 2011;21:551–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Moura D, Oliveira J, De Moura EG, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12(2):420–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for the treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61(1):19–27.CrossRefPubMedGoogle Scholar
  31. 31.
    Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the Intragastric balloon has been removed? Obes Surg. 2005;15:864–70.CrossRefPubMedGoogle Scholar
  32. 32.
    Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy. 2009;41(7):575–80.CrossRefPubMedGoogle Scholar
  33. 33.
    Gümürdülü Y, Doğan ÜB, Akın MS, et al. Long-term effectiveness of bio Enterics intragastric balloon in obese patients. Turk J Gastoenterol. 2013;24(5):387–91.CrossRefGoogle Scholar
  34. 34.
    Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22(6):896–903.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Ricardo José Fittipaldi-Fernandez
    • 1
  • Marcella Rodrigues Guedes
    • 1
  • Manoel P. Galvao Neto
    • 2
    • 3
  • Márcia Regina Simas Torres Klein
    • 4
  • Cristina Fajardo Diestel
    • 1
    • 4
  1. 1.EndogastroRio ClinicRio de Janeiro/RJBrazil
  2. 2.Gastro Obeso CenterSao PauloBrazil
  3. 3.Florida International UniversityMiamiUSA
  4. 4.Department of Applied Nutrition, Nutition InstituteRio de Janeiro State UniversityRio de Janeiro/RJBrazil

Personalised recommendations